Sanjib Saha
Lund University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sanjib Saha.
International Journal of Environmental Research and Public Health | 2010
Sanjib Saha; Ulf-G. Gerdtham; Pia Johansson
Lifestyle interventions (i.e., diet and/or physical activity) are effective in delaying or preventing the onset of diabetes and cardiovascular disease. However, policymakers must know the cost-effectiveness of such interventions before implementing them at the large-scale population level. This review discusses various issues (e.g., characteristics, modeling, and long-term effectiveness) in the economic evaluation of lifestyle interventions for the primary and secondary prevention of diabetes and cardiovascular disease. The diverse nature of lifestyle interventions, i.e., type of intervention, means of provision, target groups, setting, and methodology, are the main obstacles to comparing evaluation results. However, most lifestyle interventions are among the intervention options usually regarded as cost-effective. Diabetes prevention programs, such as interventions starting with targeted or universal screening, childhood obesity prevention, and community-based interventions, have reported favorable cost-effectiveness ratios.
International Journal of Environmental Research and Public Health | 2017
Maximilian Tremmel; Ulf-G. Gerdtham; Peter Nilsson; Sanjib Saha
Background: The rising prevalence of obesity represents an important public health issue. An assessment of its costs may be useful in providing recommendations for policy and decision makers. This systematic review aimed to assess the economic burden of obesity and to identify, measure and describe the different obesity-related diseases included in the selected studies. Methods: A systematic literature search of studies in the English language was carried out in Medline (PubMed) and Web of Science databases to select cost-of-illness studies calculating the cost of obesity in a study population aged ≥18 years with obesity, as defined by a body mass index of ≥30 kg/m², for the whole selected country. The time frame for the analysis was January 2011 to September 2016. Results: The included twenty three studies reported a substantial economic burden of obesity in both developed and developing countries. There was considerable heterogeneity in methodological approaches, target populations, study time frames, and perspectives. This prevents an informative comparison between most of the studies. Specifically, there was great variety in the included obesity-related diseases and complications among the studies. Conclusions: There is an urgent need for public health measures to prevent obesity in order to save societal resources. Moreover, international consensus is required on standardized methods to calculate the cost of obesity to improve homogeneity and comparability. This aspect should also be considered when including obesity-related diseases.
PLOS ONE | 2013
Sanjib Saha; Katarina Steen Carlsson; Ulf-G. Gerdtham; Margareta K. Eriksson; Lars Hagberg; Mats Eliasson; Pia Johansson
Background Lifestyle interventions affect patients’ risk factors for metabolic syndrome (MeSy), a pre-stage to cardiovascular diseases, diabetes and related complications. An effective lifestyle intervention is the Swedish Björknäs intervention, a 3-year randomized controlled trial in primary care for MeSy patients. To include future disease-related cost and health consequences in a cost-effectiveness analysis, a simulation model was used to estimate the short-term (3-year) and long-term (lifelong) cost-effectiveness of the Björknäs study. Methodology/ Principal Findings A Markov micro-simulation model was used to predict the cost and quality-adjusted life years (QALYs) for MeSy-related diseases based on ten risk factors. Model inputs were levels of individual risk factors at baseline and at the third year. The model estimated short-term and long-term costs and QALYs for the intervention and control groups. The cost-effectiveness of the intervention was assessed using differences-in-differences approach to compare the changes between the groups in the health care and societal perspectives, using a 3% discount rate. A 95% confidence interval (CI), based on bootstrapping, and sensitivity analyses describe the uncertainty in the estimates. In the short-term, costs are predicted to increase over time in both groups, but less in the intervention group, resulting in an average cost saving/reduction of US
Health Economics Review | 2013
Sanjib Saha; Ulf-G. Gerdtham
-700 (in 2012, US
Health Care for Women International | 2017
Sanjib Saha; Mahfuza Mubarak; Johan Jarl
1=six point five seven SEK) and US
Nordic Journal of Psychiatry | 2018
Sanjib Saha; Ulrika Bejerholm; Ulf-G. Gerdtham; Johan Jarl
-500, in the societal and health care perspectives. The long-term estimate also predicts increased costs, but considerably less in the intervention group: US
International Journal of Environmental Research and Public Health | 2018
Sanjib Saha; Ulf-G. Gerdtham; Faiza Siddiqui; Louise Bennet
-7,300 (95% CI: US
European Journal of Health Economics | 2018
Sanjib Saha; Birgitta Grahn; Ulf-Göran Gerdtham; Kjerstin Stigmar; Sara Holmberg; Johan Jarl
-19,700 to US
Trials | 2013
Sanjib Saha; Matti Leijon; Ulf Gerdtham; Kristina Sundquist; Jan Sundquist; Daniel Arvidsson; Louise Bennet
-1,000) in the societal, and US
Archive | 2018
Sanjib Saha; Ulf-Göran Gerdtham; Håkan Toresson; Lennart Minthon; Johan Jarl
-1,500 (95% CI: US